Literature DB >> 2025595

Diurnal variation in peak expiratory flow rate among polyvinylchloride compounding workers.

H S Lee1, T P Ng, Y L Ng, W H Phoon.   

Abstract

The diurnal variation in peak expiratory flow rate (PEFR) was studied in 24 mixers and 24 non-mixers in three polyvinylchloride (PVC) compounding plants and 24 non-PVC controls from a marine police workshop. The three groups (all men) were matched for age, race, and smoking. The mean respirable dust concentration (essentially PVC dust) was 1.6 mg/m3 for mixers and 0.4 mg/m3 for nonmixers. The mean diurnal variation in PEFR of the mixers was 6.5%. This was significantly higher than the 4.8% for non-mixers and 4.3% for the non-PVC controls. Six mixers had a diurnal variation of more than 15% on at least one day compared with none among the other two groups. Twenty nine per cent of mixers complained of wheezing compared with 4% of non-mixers and none among non-PVC workers. These differences were significant. Forced expiratory volume in one second (FEV1) for the mixers was 10% below the predicted values whereas that of non-PVC workers was 2% below predicted values. The study indicates a significant acute airway constriction from occupational exposure to PVC dust.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2025595      PMCID: PMC1035370     

Source DB:  PubMed          Journal:  Br J Ind Med        ISSN: 0007-1072


  11 in total

1.  Diurnal variation in peak expiratory flow rate among grain elevator workers.

Authors:  P Revsbech; G Andersen
Journal:  Br J Ind Med       Date:  1989-08

2.  Respiratory disorders among tobacco workers.

Authors:  F Lander; S Gravesen
Journal:  Br J Ind Med       Date:  1988-07

3.  Epidemiological study of respiratory disease in workers exposed to polyvinylchloride dust.

Authors:  C A Soutar; L H Copland; P E Thornley; J F Hurley; J Ottery; W G Adams; B Bennett
Journal:  Thorax       Date:  1980-09       Impact factor: 9.139

4.  Cold urticaria: release into the circulation of histamine and eosinophil chemotactic factor of anaphylaxis during cold challenge.

Authors:  N A Soter; S I Wasserman; K F Austen
Journal:  N Engl J Med       Date:  1976-03-25       Impact factor: 91.245

5.  Pulmonary function and respiratory symptoms in polyvinylchloride fabrication workers.

Authors:  M E Baser; M S Tockman; T P Kennedy
Journal:  Am Rev Respir Dis       Date:  1985-02

6.  Clinical studies of workers exposed to polyvinylchloride dust.

Authors:  C A Soutar; S Gauld
Journal:  Thorax       Date:  1983-11       Impact factor: 9.139

7.  Obstructive and restrictive ventilatory impairment in polyvinylchloride fabrication workers.

Authors:  P Ernst; L De Guire; B Armstrong; G Thériault
Journal:  Am J Ind Med       Date:  1988       Impact factor: 2.214

8.  Respiratory illness caused by overheating of polyvinyl chloride.

Authors:  B Froneberg; P L Johnson; P J Landrigan
Journal:  Br J Ind Med       Date:  1982-08

9.  Occupational asthma caused by a plastics blowing agent, azodicarbonamide.

Authors:  A J Slovak
Journal:  Thorax       Date:  1981-12       Impact factor: 9.139

10.  Phthalate ester exposure--air levels and health of workers processing polyvinylchloride.

Authors:  J Nielsen; B Akesson; S Skerfving
Journal:  Am Ind Hyg Assoc J       Date:  1985-11
View more
  4 in total

1.  Effect of the number of peak expiratory flow readings per day on the estimation of diurnal variation.

Authors:  P F Gannon; D T Newton; C F Pantin; P S Burge
Journal:  Thorax       Date:  1998-09       Impact factor: 9.139

2.  Serial nasal peak expiratory flow measurements in woodwork teachers.

Authors:  M Ahman; E Söderman
Journal:  Int Arch Occup Environ Health       Date:  1996       Impact factor: 3.015

3.  Diurnal variation in peak expiratory flow rate among workers exposed to toluene diisocyanate in the polyurethane foam manufacturing industry.

Authors:  H S Lee; W H Phoon
Journal:  Br J Ind Med       Date:  1992-06

4.  Bronchial asthma and COPD due to irritants in the workplace - an evidence-based approach.

Authors:  Xaver Baur; Prudence Bakehe; Henning Vellguth
Journal:  J Occup Med Toxicol       Date:  2012-09-26       Impact factor: 2.646

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.